ARCHIVES

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

This article is from The Cancer Letter archive.

Vol. 24 No. 34 | September 11, 1998

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 9 Issue 2, Summer 1995

June 13, 1995

In Brief: Wittes To Return To NCI As Chief Of Medicine Branch; Owens Heads Cancer Research Coalition

June 8, 1990

Five-Fold Increase in Chordoma Risk Linked to Common Gene Variant

October 26, 2012

NCAB Committee Close To Definition Of QRA

February 11, 1983

NCAB working Group Is Not Subject To Open Meetings Law, NCI Official Says

December 9, 1994

In Brief: ACS to support $2 Billion NCI Budget; NCAB Backs Minority Enhancement Core Supplements

February 19, 1988